From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 294,186 shares, representing 0.87% for KRW 2,998.6 million under the buyback announced on September 20, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,230 KRW | +2.13% | +1.80% | -29.04% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.04% | 146M | |
+14.37% | 118B | |
+12.82% | 106B | |
-3.36% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-17.66% | 15.56B | |
+4.14% | 13.63B | |
+28.12% | 12.27B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.